Waldermar Pfrengle

Title: Waldermar Pfrengle: Innovator in Medicinal Chemistry

Introduction

Waldermar Pfrengle is a notable inventor based in Biberach an der Riss, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with valuable pharmacological properties. His work focuses on innovative solutions for treating various diseases.

Latest Patents

Pfrengle holds a patent for a compound titled 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5] undecane-5-one dimaleate. This invention relates to a compound that exhibits an inhibiting effect on signal transduction mediated by tyrosine kinases. The patent also covers processes for stereoselectively preparing these compounds, particularly pharmaceutical formulations suitable for inhalation. The compound is intended for the treatment of diseases such as tumoral diseases, benign prostatic hyperplasia, and diseases of the lungs and airways.

Career Highlights

Pfrengle is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company has allowed him to contribute to groundbreaking research and development in the field of medicine. His innovative approach has led to advancements in therapeutic options for patients.

Collaborations

Throughout his career, Pfrengle has collaborated with esteemed colleagues, including Guenther Huchler and Markus Ostermeier. These collaborations have fostered a productive environment for innovation and have enhanced the development of new medicinal compounds.

Conclusion

Waldermar Pfrengle's contributions to medicinal chemistry exemplify the impact of innovative thinking in the pharmaceutical industry. His patent and collaborative efforts highlight the importance of research in developing effective treatments for various health conditions.